Abstract
The interaction among estrogen, angiotensin II (Ang II), and oxidative stress in endothelial progenitor cells (EPCs) remains unknown. We therefore investigated the potential effect of estrogen on Ang II-induced EPC oxidative stress and senescence in EPCs. EPCs were isolated from peripheral blood and characterized. Both reverse transcription (RT)−polymerase chain reaction (PCR) and Western blotting were used to assess gp91phox and angiotensin type 1 receptor (AT1R) expression. Immunofluorescence of nitrotyrosine provided evidence of peroxynitrite formation. Our data indicate that Ang II increased the expression of gp91phox mRNA and protein, and these effects were attenuated by 17β-estradiol (E2). The exposure of cultured EPCs to Ang II (100 nmol/l) significantly accelerated the rate of senescence compared to that in control cells during 14 days in culture as determined by acidic β-galactosidase staining, and this effect was significantly inhibited by E2 (p<0.01). Because cellular senescence is critically influenced by telomerase, which elongates telomeres, we measured telomerase activity by using a PCR-ELISA-based assay. Ang II significantly diminished telomerase activity, although the effect was significantly reduced by pre-treatment with E2 (p<0.01). Because we previously demonstrated that both the up-regulation of gp91phox and the acceleration of cellular senescence in Ang II-stimulated EPCs could be abolished by pre-treatment with the AT1R-specific antagonist, valsartan, we also explored the effect of estrogen on AT1R expression. Ang II increased AT1R mRNA and protein expression, and these increases were prevented by E2, suggesting that AT1R may at least partially mediate the inhibitory effect of E2 on Ang II-induced acceleration of senescence in EPCs. In conclusion, estrogen reduces Ang II-induced acceleration of senescence in EPCs partially through down-regulation of AT1R expression.
Similar content being viewed by others
Article PDF
References
Asahara T, Murohara T, Sullivan M, et al: Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964–967.
Shi Q, Rafii S, Wu MH, et al: Evidence for circulating bone marrow-derived endothelial cells. Blood 1998; 92: 362–367.
Edelberg JM, Tang L, Hattori K, Lyden D, Rafii S : Young adult bone marrow-derived endothelial precursor cells rescue aging-impaired cardiac angiogenic function. Circ Res 2002; 90: E89–E93.
Vasa M, Fichtlscherer S, Aicher A, et al: Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001; 89: e1–e7.
Hill JM, Zalos G, Halcox JPJ, et al: Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348: 593–600.
Scheubel RJ, Zorn H, Silber R-E, et al: Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol 2003; 42: 2073–2080.
Kalka C, Masuda H, Takahashi T, et al: Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells. Circ Res 2000; 86: 1198–1202.
Murasawa S, Llevadot J, Silver M, Isner JM, Losordo DW, Asahara T : Constitutive human telomerase reverse transcriptase expression enhances regenerative properties of endothelial progenitor cells. Circulation 2002; 106: 1133–1139.
Min TQ, Zhu CJ, Xiang WX, Hui ZJ, Peng SY : Improvement in endothelial progenitor cells from peripheral blood by ramipril therapy in patients with stable coronary artery disease. Cardiovasc Drugs Ther 2004; 18: 203–209.
Dubey RK, Oparil S, Imthurn B, Jackson EK : Sex hormones and hypertension. Cardiovasc Res 2002; 53: 688–708.
Gragasin FS, Xu Y, Arenas IA, Kainth N, Davidge ST : Estrogen reduces angiotensin II-induced nitric oxide synthase and NAD(P)H oxidase expression in endothelial cells. Arterioscler Thromb Vasc Biol 2003; 23: 38–44.
Nickenig G, Baumer AT, Grohe C, et al: Estrogen modulates AT1 receptor gene expression in vitro and in vivo. Circulation 1998; 97: 2197–2201.
Imanishi T, Hano T, Nishio I : Angiotension II accelerates endothelial progenitor cells senescence through induction of oxidative stress. J Hypertens 2005; 23: 97–104.
Imanishi T, Hano T, Matsuo Y, Nishio I : Oxidized LDL inhibits vascular endothelial growth factor-induced endothelial progenitor cell differentiation. Clin Exp Pharmacol Physiol 2003; 30: 665–670.
Imanishi T, Hano T, Nishio I : Angiotensin II potentiates VEGF-induced proliferation, and network formation in endothelial progenitor cells. Hypertens Res 2004; 27; 101–108.
Imanishi T, McBride J, Ho Q, O'Brien KD, Schwartz SM, Han DK : Expression of cellular FLICE-inhibitory protein in human coronary arteries and in a rat vascular injury model. Am J Pathol 2000; 156: 125–137.
Dimri GP, Lee X, Basile G, et al: A biomarker that identifies senescent human cells in culture and in aging skin in vitro. Proc Natl Acad Sci U S A 1995; 92: 9363–9367.
Imanishi T, Hano T, Sawamura T, Nishio I : Oxidized low-density lipoprotein induces endothelial progenitor cell senescence, leading to cellular dysfunction. Clin Exp Pharmacol Physiol 2004; 31: 407–413.
Dimmeler S, Rippmann V, Weiland U, Haendeler J, Zeiher AM : Angiotensin II induces apoptosis of human endothelial cells. Protective effect of nitric oxide. Circ Res 1997; 81: 970–976.
Ichiki T, Takeda K, Tokunou T, et al: Downregulation of angiotensin II type 1 receptor gene transcription by nitric oxide. Hypertension 1998; 31: 342–348.
Li D, Saldeen T, Romeo F, Mehta JL : Oxidized LDL upregulates angiotensin II type 1 receptor expression in cultured human coronary artery endothelial cells: the potential role of transcription factor NF-κB. Circulation 2000; 102: 1970–1976.
Ruiz-Ortega M, Lorenzo O, Ruperez M, Konig S, Wittig B, Egido J : Angiotensin II activates nuclear transcription factor κB through AT1 and AT2 in vascular smooth muscle cells: molecular mechanisms. Circ Res 2000; 86: 1266–1272.
Cooke CL, Davidge ST : Peroxynitrite increases iNOS through NF-κB and decreases prostacyclin synthase in endothelial cells. Am J Physiol Cell Physiol 2002; 282: C395–C402.
Touyz RM, Endemann D, He G, Li JS, Schiffrin EL : Role of AT2 receptors in angiotensin II-stimulated contraction of small mesenteric arteries in young SHR. Hypertension 1999; 33: 366–372.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Imanishi, T., Hano, T. & Nishio, I. Estrogen Reduces Angiotensin II-Induced Acceleration of Senescence in Endothelial Progenitor Cells. Hypertens Res 28, 263–271 (2005). https://doi.org/10.1291/hypres.28.263
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1291/hypres.28.263
Keywords
This article is cited by
-
Estrogen normalizes maternal HFD-induced vascular dysfunction in offspring by regulating ATR
Hypertension Research (2022)
-
Chronic Intermittent Hypoxia Triggers a Senescence-like Phenotype in Human White Preadipocytes
Scientific Reports (2020)
-
The role of estrogen deficiency in skin ageing and wound healing
Biogerontology (2012)
-
Premature T cell senescence in Ovx mice is inhibited by repletion of estrogen and medicarpin: a possible mechanism for alleviating bone loss
Osteoporosis International (2012)
-
Effects of the Antioxidative -Blocker Celiprolol on Endothelial Progenitor Cells in Hypertensive Rats
American Journal of Hypertension (2008)